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ABSTRACT
Bioinformatics analysis has been performed on c-Myc peptide sequences to predict its epitopes in
order to design antigen for IgY anti-c-Myc production in chickens. Peptide sequences for human c-Myc
protein obtained from the NCBI database were analyzed with ProPred-1 softwares. Manual screening has
been conducted on the prediction results.One candidate of c-Myc epitope, EQKLISEEDL, have been selected
and prepared as an antigen, by adding one molecule of Cystein to the peptide, and conjugated it with
Keyhole limpet hemocyanin (KLH). Twelve hens, aged 22-24 weeks, were immunized a week after their first
eggs were produced. Antigen diluted in aquabidest and emulsified with Freund’s Complete Adjuvant. The
suspension was injected into the area of the chicken breast, subcutaneously or intramuscularly, with a dose
of 0.1 mg for  the first immunization. Booster injection  performed on days 10, 20, and 30 with the same
volume of emulsion, but using Incomplete Freund’s Adjuvant and the amount of antigen half of the first
immunization. Extraction of IgY from egg has been carried out using kits from Gallus Immunotech. IgY levels
quantified using a spectrophotometer, absorbance measured at 280 nm. The results showed that chicken
antibody production gave rise to a sigmoid curve pattern, just like in mammals. The IgY content of the egg
was stable at high levels (> 5 mg / ml yolk) after the third immunization. In the intramuscular group, the
immune response seems to work earlier than in the subcutaneous group, but eventually the subcutaneous
group reaches the same level, and even higher. In general, from an egg produced after the second booster it
can be extracted at least 50 mg of IgY. Higher yields could  be obtained when IgY was extracted from egg 2
to 3 days after the third booster.
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INTRODUCTION
Antibody was initially used for therapy, but now it has been used in many fields of re-
search for various purposes. Antibody can be used in  the characterization and quantifica-
tion of specific protein, or in verification of protein localization. Its usefulness as tools for
many biomedical researchers is due to its ability to recognize and bind to a specific target
molecule. Many antibodies today have been used in diagnostic applications, such as in
pregnancy test kits, in protein microarrays, in immunohistochemistry, and ELISA. Increase
widespread use has led to increased  demand for antibodies  (Anonymous, 2011).  Unfortu-
nately, for developing countries like Indonesia most of domestic demand for antibodies are
met by imports. Attempts to produce antibodies domestically face problem of expertise,
equipment and high production costs.
Most of  antibodies in the market today are produced in the mammalian bodies. There
were several disadvantages of this mode of production. Firstly, this mode of production re-
sulting in relatively small quantity of antibody. It is only a very small quantity of antibody that
can be extracted from blood. Secondly, there is a problem with cross-reaction phenomenon,
when the antibodies from one mammalian species is used as a diagnostic tool for other
mammals. Thirdly, there is  ethical implication when produce antibodies in mammalian
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bodies.  The technique  usually generates stress and pain in the animals,  due to injection of
antigen and adjuvant and repeated blood sampling in large volume for antibodies extraction.
These problems should be solved by  production of monoclonal antibodies in vitro. How-
ever, the production of monoclonal antibodies requires special expertise and very expen-
sive laboratory equipment.
As an alternative to the production of antibodies in the mammalian, Polson (1990) has
developed techniques to produce antibody in poultry. With this new technique, the results
obtained are larger. In the chicken, 20-30 mg of antigen was able to produce 130 mg of
specific antibodies. IgY antibodies provide the added advantage of minimal cross-reaction
when used as tools for detection of mammalian protein (Gassmann et al., 1990). In addition,
since  IgY is extracted from eggs, the production system is essentially generated no pain
and low stress-effects in  experimental animals.
Production of antibodies, both in mammal and in poultry, requires precise design of an
immunogen that able to trigger body  immune response. As is generally known, for generat-
ing an immune response it does not need to use the whole protein as an antigen, but quite a
small segment of the protein known as antigenic determinant or epitope. Determination of
epitope of a protein is a very complex job. Factors to be considered in epitope prediction
and design of the immunogen include: i). Epitope length (generally in the range of 10-20
residues), ii). Hydrophobicity, surface orientation, and flexibility, iii). Targeting the N-terminus
or C-terminus, iv). Continuous and discontinuous epitopes, v). Algorithms to predict protein
characteristics such as hydrophilicity / hydrophobicity and secondary structure of the region
including the alpha-helix, beta sheet, vi). The selection process of the sequence,  such as
avoiding common sequence motifs (e.g. RGD motif, helix-loop-helix sequence, GTP bind-
ing sites, and SH2 domains) that can cause cross-reactivity, and vii). Coupling  of peptides
to carrier protein (Ponomarenkom and van Regenmortel., 2009). Because of the impor-
tance of immunogen design, epitopes prediction has become a specialized field of  immu-
nology which is rapidly evolving. Currently, prediction of epitope can be done efficiently with
the help of computer programs. There are many computer programs available with the abil-
ity to  predict epitopes. Some of them rely solely on the information  which can be obtained
from the linear sequence of protein antigen, for example ABCpred (Saha & Raghava, 2006)
and COBEpro (Sweredoski & Baldi, 2009), while others depend on the availability of three-
dimensional structures, such as the CEP program (Kulkarni-Kale et al., 2005) and DiscoTope
(Andersen & Lund, 2006). There are also programs that can analyze both 3-D protein struc-
ture and peptide linear sequence, such as program Epitopia (Rubinstein et al.,  2009), and
programs targeting the MHC-binding peptides such as ProPred (Singh & Raghava, 2001).
In this paper, production of IgY anti-c-Myc  in chickens were reported. The c-Myc antibody
was chosen to produce, because it  is widely used in many research areas, among others, in
relation to health, developmental biology, and research on R&D and evaluation of plant-
based drugs for cancer therapy (He et al., 2008). The c-Myc protein is generally activated in




Sequence for analysis were mRNA  of the human c-Myc protein in Fasta format. The
sequences of 454 amino acid peptide size were obtained from the NCBI database (RefSeq/
protein_id = NP_002458.2):
A personal computer connected to the internet was used. Analysis was accomplished
online, by connecting to http://www.imtech.res.in/raghava/propred1/ (ProPred-1 server).
ProPred-1 predict epitopes that can bind to alleles of MHC class I molecules. This program
uses a matrix-based antigen sequence for 47 MHC class-I alleles. ProPred-1 provides the
option for the analysis of one allele, the combination of multiple alleles, or analysis of all 47
alleles.
Data of human c-Myc peptide  sequence was copy-pasted to the ProPred-1 server in
Fasta format. Twelve MHC class I alleles were selected to be analyzed. A threshold score of
4% (default) and output display in HTML-II format were selected. The program processed
the data for several minutes (time depends on the length of the sequence entered). Predic-
tion results were screened manually to obtain a candidate of epitope with 10 amino acids
size. Five upper  ranked of sequences resulting from software prediction were manually
screened to obtain one candidate of epitope with 10 amino acids size. Candidate wherever
possible have to meet  the following criteria: i). Does not contain Proline, Cystein, and Me-
thionine, ii). Possessed more exposed (e) than buried (b) amino acids, iii.) Not from helical
regions of the protein. iv). Does not contain N-terminal Aspergine. v). Does not contain as-
partic acid in combination with Glycine, Proline, and Serine. vi). No multiple Serine and
Proline, and  vii). No serial order of Glutamine, Isoleusine, Leusine, Phenylalanine, Threo-
nine, Tyrosine, or Valin (Angeletti, 1999; Anonymous, 2012).
Immunization protocol
Twelve hens, 22-24 weeks of age, purchased from a breeder and kept in battery cages.
Animals were fed commercial feed (chicken par-G-pellets) and received tap water ad libi-
tum. The immunization was started on the day 7 after chickens started laying eggs. Syn-
thetic c-Myc peptide (Genescript)  (0.1 mg) were diluted in aquabidest, until the final volume
of 750 ml. Antigen solution was then emulsified with an equal volume of Freund’s Complete
Adjuvant (Pacific Immunology., A#5003). For subcutaneous route of immunization, suspen-
sion was injected into the space under the skin in the breast area. Subsequent immunization
was applied on days 10, 20, and 30 with the same volume of emulsion, but using Incomplete
Freund’s Adjuvant and the amount of antigen half of the first. For the intramuscular immuniza-
tion route, the suspension was injected  into the breast muscle. Eggs were collected daily,
marked and stored at 4°C until use. Eggs that collected prior to immunization were used as
controls.
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IgY extraction and quantification
IgY antibody was extracted using the EggsPress IgY Purification Kit (Gallus Immunotech
Inc.). Yolk was separated from the white egg using an egg separator. Yolk then rinsed with
distilled water and 5 volumes of Reagent A (4°C) were added very slowly. Suspension stirred
until it well blended and then kept in refrigerator at 4°C overnight. Suspension then  centri-
fuged at 4000 X g for 20 min at 4°C. Supernatant was collected into a beaker glass and an
equal volume of reagent B (4°C) was added while stirring gently for 2 minutes. The suspen-
sion centrifuged again, at 4000 X g for 20 min at 4°C. After that, the supernatant was dis-
carded and the precipitate obtained (IgY) was diluted in PBS. Absorbance was measured
with a spectrophotometer at 280 nm for quantification. IgY antibody  was filter sterilized   and
stored in the refrigerator.
RESULT AND DISCUSSION
Epitope prediction
Analysis of c-Myc protein sequences with the program ProPred-1 produces several
epitope candidates. After a manual screening procedure, one  segment of 10 amino acids
(EQKLISEEDL) was selected and    developed  into an antigen. The epitope is located in
number  426-434   of c-Myc peptide. It has a high  immunogenicity scale at 7 of its amino
acid, moderate for  one amino acid, and low for other amino acids. Amino acids with low
immunogenicity scale in this segment is Leusine, which is  not an exposed amino acid. A
synthetic peptide was  purchased  with custom by sending information to  GenScript com-
pany, USA. The information provided as a basis for the synthesis were the peptide seg-
ments (EQKLISEEDL), the addition of Cystein to the terminal of the sequence,  and conju-
gation to carrier proteins. Because the peptides are generally too small to generate suffi-
cient immune response to produce antibodies,   the peptide was conjugated to a carrier
protein to stimulate T-helper cells, which induces B cells to generate immune responses.
Keyhole limpet hemocyanin (KLH), a copper-core molecules containing non-heme proteins
found in arthropods and mollusks, were used as carrier protein. KLH conjugate was chosen
because its  higher imunogenicity compared to other carrier proteins.
IgY production
Synthetic antigen  containing a short sequence of peptide resulted from the computer
program prediction (ProPred-1) was capable of eliciting an immune response in chickens
(Figure 1). The antibody production gives a sigmoid curve pattern, just like in mammals
(Hanly et al., 1995).
In figure 1, D0 eggs (collected   before immunization)   was evidently also contains anti-
bodies at low rates (1, 084 mg/ml). This means that, naturally chicken body received various
antigens and responded to them by producing antibodies. However, the amount of antibody
produced by natural antigen is relatively small compared to the amount  produced by the
immunization process (Harskin, 2001).
In the intramuscular group, the immune response seems to work earlier than in the sub-
cutaneous group, but eventually the subcutaneous group reaches the same level, and even
higher. Two days after the first immunization (D2), IgY level has reached 4.646 mg/ml yolk,
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while in subcutaneous group it was only 2.876 mg/ml (P<0.05). After that time IgY levels
decreased  in both groups and only  increased after the second booster was given (D10) and
reached the same level in D
12
 (P>0.05). After third immunization (D
20
), IgY level was con-
stantly  higher in the subcutaneous group where it was  relatively stable at a level of 6 to 7 mg/
ml yolk as detected  in D18 and D28 eggs (P<0.05). Based on these differences, and the fact
that subcutaneous immunization causes minimal pain to the chicken, it is suggested that in
the process of IgY production, it is better if the immunization was given by subcutaneous
rather than intramuscular injection. On subcutaneous route, chicken experiment showed no
pain and rejection, in contrast to  intramuscular injections that always causes chicken floun-
dered and struggled.
In general, from an egg produced after the second booster it can be extracted at least
50 mg of IgY. Higher yields could  be obtained when IgY was extracted from egg 2 to 3 days
after the third booster.
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